Endotoxin tolerance disrupts chromatin remodeling and NF-κB transactivation at the IL-1β promoter

Journal of Immunology

Volumn 175, Issue 1, 2005, Pages 461-468

  Chan, Christopher ^a   Li, Liwu ^a,b,c   McCall, Charles E ^a,c   Yoza, Barbara K ^a,c,d  

^a Department of Internal Medicine   (United States)

^b Section on Infectious Diseases   (United States)

^c Section of Molecular Medicine   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LYSINE; PROTEIN P50; SERINE;

ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; LEUKOCYTE; METHYLATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; TRANSACTIVATION;

EID: 21244481640     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.1.461     Document Type: Article

References (53)

1. Angus, D. C., and R. S. Wax. 2001. Epidemiology of sepsis: an update. Crit. Care Med. 29: S109-S116.
2. Bone, R. C., C. J. Grodzin, and R. A. Balk. 1997. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112: 235-243.
3. Beutler, B., K. Hoebe, X. Du, and R. J. Ulevitch. 2003. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J. Leukocyte Biol. 74: 479-485.
4. Cavaillon, J. M., C. Fitting, and M. dib-Conquy. 2004. Mechanisms of immunodysregulation in sepsis. Contrib. Nephrol. 144: 76-93.
5. Fan, H., and J. A. Cook. 2004. Molecular mechanisms of endotoxin tolerance. J. Endotoxin Res. 10: 71-84.
6. West, M. A., and W. Heagy. 2002. Endotoxin tolerance: a review. Crit. Care Med. 30: S64-S73.
7. Cogswell, J. P., M. M. Godlevski, G. B. Wisely, W. C. Clay, L. M. Leesnitzer, J. P. Ways, and J. G. Gray. 1994. NF-κB regulates IL-1β transcription through a consensus NF-κB binding site and a nonconsensus CRE-like site. J. Immunol. 153: 712-723.
8. Baldwin, A. S. 2004. NFκB: biology and pathology-Keystone Symposium. 11-16 January 2004, Snowbird, UT, USA. IDrugs 7: 215-216.
9. Baldwin, A. S. 2001. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J. Clin. Invest. 107: 241-246.
10. Schmitz, M. L., I. Mattioli, H. Buss, and M. Kracht. 2004. NF-κB: a multifaceted transcription factor regulated at several levels. Chembiochem 5: 1348-1358.
11. Kastenbauer, S., and H. W. Ziegler-Heitbrock. 1999. NF-κB1 (p50) is upregulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression. Infect. Immun. 67: 1553-1559.
12. Pahl, H. L. 1999. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18: 6853-6866.
13. Arnalich, F., E. Garcia-Palomero, J. Lopez, M. Jimenez, R. Madero, J. Renart, J. J. Vazquez, and C. Montiel. 2000. Predictive value of nuclear factor κB activity and plasma cytokine levels in patients with sepsis. Infect. Immun. 68: 1942-1945.
14. Bohuslav, J., V. V. Kravchenko, G. C. Parry, J. H. Erlich, S. Gerondakis, N. Mackman, and R. J. Ulevitch. 1998. Regulation of an essential innate immune response by the p50 subunit of NF-κB. J. Clin. Invest. 102: 1645-1652.
15. Bohrer, H., F. Qiu, T. Zimmermann, Y. Zhang, T. Jllmer, D. Mannel, B. W. Bottiger, D. M. Stern, R. Waldherr, H. D. Saeger, et al. 1997. Role of NFκB in the mortality of sepsis. J. Clin. Invest. 100: 972-985.
16. McCall, C. E., L. M. Grosso-Wilmoth, K. LaRue, R. N. Guzman, and S. L. Cousart. 1993. Tolerance to endotoxin-induced expression of the interleukin-1β gene in blood neutrophils of humans with the sepsis syndrome. J. Clin. Invest. 91: 853-861.
17. Mueller, L. P., B. K. Yoza, K. Neuhaus, C. S. Loeser, S. Cousart, M. C. Chang, J. W. Meredith, L. Li, and C. E. McCall. 2001. Endotoxin-adapted septic shock leukocytes selectively alter production of sIL-1RA and IL-1β. Shock 16: 430-437.
18. Adib-Conquy, M., C. Adrie, P. Moine, K. Asehnoune, C. Fitting, M. R. Pinsky, J. F. Dhainaut, and J. M. Cavaillon. 2000. NF-κB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. Am. J. Respir. Crit Care Med. 162: 1877-1883.
19. Heagy, W., K. Nieman, C. Hansen, M. Cohen, D. Danielson, and M. A. West. 2003. Lower levels of whole blood LPS-stimulated cytokine release are associated with poorer clinical outcomes in surgical ICU patients. Surg. Infect. 4: 171-180
20. Smale, S. T., and A. G. Fisher. 2002. Chromatin structure and gene regulation in the immune system. Annu. Rev. Immunol. 20: 427-462.
21. Berger, F., and V. Gaudin. 2003. Chromatin dynamics and arabidopsis development. Chromosome Res. 11: 277-304.
22. Cheung, P., C. D. Allis, and P. Sassone-Corsi. 2000. Signaling to chromatin through histone modifications. Cell 103: 263-271.
23. Fischle, W., Y. Wang, and C. D. Allis. 2003. Binary switches and modification cassettes in histone biology and beyond. Nature 425: 475-479.
24. Munoz, C., J. Carlet, C. Fitting, B. Misset, J. P. Bleriot, and J. M. Cavaillon. 1991. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88: 1747-1754.
25. LaRue, K. E., and C. E. McCall. 1994. A labile transcriptional repressor modulates endotoxin tolerance. J. Exp. Med. 180: 2269-2275.
26. Yoza, B. K., J. Y. Hu, S. L. Cousart, and C. E. McCall. 2000. Endotoxin inducible transcription is repressed in endotoxin tolerant cells. Shock 13: 236-243.
27. Yoza, B., K. LaRue, and C. McCall. 1998. Molecular mechanisms responsible for endotoxin tolerance. Prog. Clin. Biol. Res. 397: 209-215.
28. Yoza, B. K., J. Y. Hu, and C. E. McCall. 1996. Protein-tyrosine kinase activation is required for lipopolysaccharide induction of interleukin 1β and NFκB activation, but not NFκB nuclear translocation. J. Biol. Chem. 271: 18306-18309.
29. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109(Suppl.): S81-S96.
30. Smale, S. T., and J. T. Kadonaga. 2003. The RNA polymerase II core promoter. Annu. Rev. Biochem. 72: 449-479.
31. Strassheim, D., J. S. Park, and E. Abraham. 2002. Sepsis: current concepts in intracellular signaling. Int. J. Biochem. Cell Biol. 34: 1527-1533.
32. Abraham, E. 2003. Nuclear factor-κB and its role in sepsis-associated organ failure. J. Infect. Dis. 187(Suppl. 2): S364-S369.
33. Angelov, D., F. Lenouvel, F. Hans, C. W. Muller, P. Bouvet, J. Bednar, E. N. Moudrianakis, J. Cadet, and S. Dimitrov. 2004. The histone octamer is invisible when NF-κB binds to the nucleosome. J. Biol. Chem. 279: 42374-42382.
34. Hoberg, J. E., F. Yeung, and M. W. Mayo. 2004. SMRT derepression by the IκB kinase α: a prerequisite to NF-κB transcription and survival. Mol. Cell 16: 245-255.
35. Ziegler-Heitbrock, H. W., A. Wedel, W. Schraut, M. Strobel, P. Wendelgass, T. Sternsdorf, P. A. Bauerle, J. G. Haas, and G. Riethmuller. 1994. Tolerance to lipopolysaccharide involves mobilization of nuclear factor κB with predominance of p50 homodimers. J. Biol. Chem. 269: 17001-17004.
36. Ziegler-Heitbrock, L. 2001. The p50-homodimer mechanism in tolerance to LPS. J. Endotoxin Res. 7: 219-222.
37. Jonas, B. A., and M. L. Privalsky. 2004. SMRT and N-CoR corepressors are regulated by distinct kinase signaling pathways. J. Biol. Chem. 279: 54676-54686.
38. Privalsky, M. L. 2001. Regulation of SMRT and N-CoR corepressor function. Curr. Top. Microbiol. Immunol. 254: 117-136.
39. Fischle, W., Y. Wang, and C. D. Allis. 2003. Histone and chromatin cross-talk. Curr. Opin. Cell Biol. 15: 172-183.
40. Saccani, S., and G. Natoli. 2002. Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. Genes Dev. 16: 2219-2224.
41. Hebbar, P. B., and T. K. Archer. 2003. Nuclear factor 1 is required for both hormone-dependent chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter. Mol. Cell Biol. 23: 887-898.
42. Smale, S. T. 2001. Core promoters: active contributors to combinatorial gene regulation. Genes Dev. 15: 2503-2508.
43. Carter, A. B., K. L. Knudtson, M. M. Monick, and G. W. Hunninghake. 1999. The p38 mitogen-activated protein kinase is required for NF-κB-dependent gene expression: the role of TATA-binding protein (TBP). J. Biol. Chem. 274: 30858-30863.
44. Carter, A. B., M. M. Monick, and G. W. Hunninghake. 1999. Both Erk and p38 kinases are necessary for cytokine gene transcription. Am. J. Respir. Cell Mol. Biol. 20: 751-758.
45. Madrid, L. V., M. W. Mayo, J. Y. Reuther, and A. S. Baldwin, Jr. 2001. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276: 18934-18940.
46. Yamamoto, Y., and R. B. Gaynor. 2004. IκB kinases: key regulators of the NF-κB pathway. Trends Biochem. Sci. 29: 72-79.
47. Prajapati, S., U. Verma, Y. Yamamoto, Y. T. Kwak, and R. B. Gaynor. 2004. Protein phosphatase 2Cβ association with the IκB kinase complex is involved in regulating NF-κB activity. J. Biol Chem. 279: 1739-1746.
48. Saccani, S., S. Pantano, and G. Natoli. 2002. p38-Dependent marking of inflammatory genes for increased NF-κB recruitment. Nat. Immunol. 3: 69-75.
49. Anest, V., J. L. Hanson, P. C. Cogswell, K. A. Steinbrecher, B. D. Strahl, and A. S. Baldwin. 2003. A nucteosomal function for IκB kinase-α in NF-κB-dependent gene expression. Nature 423: 659-663.
50. Yamamoto, Y., U. N. Verma, S. Prajapati, Y. T. Kwak, and R. B. Gaynor. 2003. Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression. Nature 423: 655.
51. Akira, S., and S. Sato. 2003. Toll-like receptors and their signaling mechanisms. Scand. J. Infect. Dis. 35: 555-562.
52. Akira, S., and K. Takeda. 2004. Functions of Toll-like receptors: lessons from KO mice. C. R. Biol. 327: 581-589.
53. O'Neill, L. A., Z. Brown, and S. G. Ward. 2003. Toll-like receptors in the spotlight. Nat. Immunol. 4: 299.